A Bioequivalence Study of Two Formulations of Oral Semaglutide in Healthy Participants
Authors
- Lise Brøndsted
- Martin Kankam
- Mette S. Nielsen (ORCID: https://orcid.org/0000-0001-7354-4648)
- Trine Vang Skjøth (ORCID: https://orcid.org/0009-0001-4101-4703)
- Marloes van Hout (ORCID: https://orcid.org/0000-0002-5753-9563)
- Usha Rani H. Patted (ORCID: https://orcid.org/0000-0002-4815-3300)
- D. Le Nguyen (ORCID: https://orcid.org/0009-0005-8562-1977)
- Gaetano Morelli (ORCID: https://orcid.org/0009-0005-8238-8751)
Institutions
- Novo Nordisk (Denmark) (DK)
- Altasciences (Canada) (CA)
- Altasciences Clinical Research Vince & Associates (US)
- Novo Nordisk (India) (IN)